Literature DB >> 16979342

Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.

Chuanwen Sun1, Xiaodong Zhang, Hai Huang, Pei Zhou.   

Abstract

A series of substituted acyl(thio)urea and 2H-1,2,4-thiadiazolo [2,3-a] pyrimidine derivatives were prepared and both of their cell culture and enzymatic activity toward influenza virus were tested. Their in vitro neuraminidase inhibitory activities were in good agreement with the corresponding activities in cultured cells and they were evaluated as potent neuraminidase inhibitors. Of the analogues that demonstrated IC(50)s<0.1microM, 16 and 60 were further investigated as candidates with the most potential for future development. The molecular docking work of the representative compound was described to provide more insight into their mechanism of action and further rationalize the observations of this new series herein, which represents a novel class of highly potent and selective inhibitors of influenza virus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979342     DOI: 10.1016/j.bmc.2006.08.034

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Docking and 3D QSAR study of thiourea analogs as potent inhibitors of influenza virus neuraminidase.

Authors:  Jiaying Sun; Shaoxi Cai; Hu Mei; Jian Li; Ning Yan; Yuanqiang Wang
Journal:  J Mol Model       Date:  2010-03-07       Impact factor: 1.810

2.  Consensus QSAR model for identifying novel H5N1 inhibitors.

Authors:  Nitin Sharma; Chun Wei Yap
Journal:  Mol Divers       Date:  2012-07-21       Impact factor: 2.943

3.  Feasible Synthesis of Antagonist of GPR40 by Constructing 2-Thiouracil Ring viaAcid Mediated Cyclization.

Authors:  Yongfeng Zhao; Yang Song; Xiulin Shen; Jiayu Liao
Journal:  Heterocycles       Date:  2011-05-01       Impact factor: 0.831

4.  Structure Optimization of Neuraminidase Inhibitors as Potential Anti-Influenza (H1N1Inhibitors) Agents Using QSAR and Molecular Docking Studies.

Authors:  Poonam Inamdar; Shashikant Bhandari; Bhagyashri Sonawane; Asha Hole; Chintamani Jadhav
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.